Related Experiment Video
Updated: Dec 8, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Non-alcoholic fatty liver disease.
1Barts Liver Centre, London, UK.
Non-alcoholic fatty liver disease (NAFLD), a common liver condition linked to metabolic syndrome, is rising globally. This review covers NAFLD
Area of Science:
- Hepatology and Gastroenterology
- Metabolic Disorders
- Public Health Epidemiology
Background:
- Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease globally.
- NAFLD is characterized by hepatic fat accumulation and is closely associated with metabolic syndrome.
- The increasing prevalence of NAFLD correlates with the global obesity epidemic and related conditions like type 2 diabetes, hypertension, and hypercholesterolemia.
Purpose of the Study:
- To summarize the current epidemiology of NAFLD.
- To outline the clinical approach for assessing patient risk.
- To briefly review existing and emerging management strategies for NAFLD.
Main Methods:
- Literature review focusing on NAFLD epidemiology.
- Analysis of clinical guidelines for risk assessment.
- Overview of current therapeutic and investigational treatments.
Main Results:
- NAFLD prevalence is increasing worldwide, mirroring obesity trends.
- Patients with NAFLD face elevated risks for cardiovascular disease and cancer.
- A subset of NAFLD patients develops significant liver damage.
Conclusions:
- NAFLD is a major global health concern with significant comorbidities.
- Effective risk stratification and management are crucial for improving patient outcomes.
- Ongoing research is vital for developing novel therapeutic interventions.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test